Matteo G. Porta-Della

Via G. B. Grassi, 74
Milan, 20174, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 161 publications

Post-Diagnostic Diet and Breast Cancer Outcomes: A Comprehensive Systematic Review of Prospective Cohort Studies and Randomized Clinical Trials.

Post-Diagnostic Diet and Breast Cancer Outcomes: A Comprehensive Systematic Review of Prospective Cohort Studies and Randomized Clinical Trials.

Journal: Nutrients

Published: June 04, 2026

Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution.

Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution.

Journal: NEJM evidence

Published: May 26, 2026

Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

Journal: Blood advances

Published: April 07, 2026

Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 27, 2026

Systemic Endotoxemia, Inflammatory Activation, and Lipid Dysregulation in Parkinson's Disease: Evidence from Circulating LPS-Related Biomarkers and Plasma Lipids.

Systemic Endotoxemia, Inflammatory Activation, and Lipid Dysregulation in Parkinson's Disease: Evidence from Circulating LPS-Related Biomarkers and Plasma Lipids.

Journal: International journal of molecular sciences

Published: March 20, 2026

Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

Journal: Blood cancer journal

Published: March 13, 2026

ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

Journal: Blood advances

Published: January 20, 2026

Treat-to-target optimization of biologic therapy is effective on endoscopic and histologic outcomes in a real-life cohort of ulcerative colitis-the TACTIC-UC study.

Treat-to-target optimization of biologic therapy is effective on endoscopic and histologic outcomes in a real-life cohort of ulcerative colitis-the TACTIC-UC study.

Journal: Journal of Crohn's & colitis

Published: December 27, 2025

A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant Cancers.

A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant Cancers.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia.

CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia.

Journal: Blood cancer journal

Published: November 14, 2025

How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

Journal: Leukemia

Published: November 08, 2025

Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast Cancer.

Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast Cancer.

Journal: JCO clinical cancer informatics

Published: November 06, 2025

Showing 1-12 of 161

Last Updated: 09/26/2026